These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11578010)

  • 21. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.
    Steen VD; Medsger TA; Rodnan GP
    Ann Intern Med; 1982 Nov; 97(5):652-9. PubMed ID: 7137731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.
    van den Hoogen FH; Boerbooms AM; Swaak AJ; Rasker JJ; van Lier HJ; van de Putte LB
    Br J Rheumatol; 1996 Apr; 35(4):364-72. PubMed ID: 8624641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y; Kohriyama K; Matsui T
    J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment.
    Pasquali Ronchetti I; Guerra D; Quaglino D; Vincenzi D; Manzini E; Canossi B; Manzini CU
    Clin Exp Rheumatol; 1989; 7(4):373-83. PubMed ID: 2591110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
    Jimenez SA; Sigal SH
    J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial.
    Brewer EJ; Giannini EH; Kuzmina N; Alekseev L
    N Engl J Med; 1986 May; 314(20):1269-76. PubMed ID: 3517643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
    Furst DE; Clements PJ; Wong WK; Mayes MD; Wigley F; White B; Weisman M; Barr W; Moreland L; Martin R; Medsger TA; Steen V; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Peter JB; Seibold JR
    Rheumatology (Oxford); 2001 Jun; 40(6):615-22. PubMed ID: 11426017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials for pediatric scleroderma.
    Rosenkranz ME; Lehman TJ
    Curr Rheumatol Rep; 2002 Dec; 4(6):449-51. PubMed ID: 12427357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postural changes, dysphagia, and systemic sclerosis.
    Barrera P; den Broeder AA; van den Hoogen FH; van Engelen BG; van de Putte LB
    Ann Rheum Dis; 1998 Jun; 57(6):331-8. PubMed ID: 9771206
    [No Abstract]   [Full Text] [Related]  

  • 31. Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
    Mayes MD; O'Donnell D; Rothfield NF; Csuka ME
    Arthritis Rheum; 2004 Feb; 50(2):553-7. PubMed ID: 14872498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Connective tissue changes in systemic sclerosis and the use of D-penicillamine.
    Jayson MI
    Agents Actions Suppl; 1979; (5):149-57. PubMed ID: 294132
    [No Abstract]   [Full Text] [Related]  

  • 33. [A prospective study of plasma exchange in the treatment of diffuse scleroderma].
    Ding C; Zhang X
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):616-9. PubMed ID: 8697930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapies for systemic sclerosis.
    Denton CP; Black CM
    Springer Semin Immunopathol; 2001; 23(1-2):109-29. PubMed ID: 11455851
    [No Abstract]   [Full Text] [Related]  

  • 35. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
    Davis P; Bleehen SS
    Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
    Rook AH; Freundlich B; Jegasothy BV; Perez MI; Barr WG; Jimenez SA; Rietschel RL; Wintroub B; Kahaleh MB; Varga J
    Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organizing diffuse alveolar damage associated with progressive systemic sclerosis.
    Muir TE; Tazelaar HD; Colby TV; Myers JL
    Mayo Clin Proc; 1997 Jul; 72(7):639-42. PubMed ID: 9212765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of scleroderma heart by D-penicillamine.
    Muers M; Stokes W
    Br Heart J; 1976 Aug; 38(8):864-7. PubMed ID: 135572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of D-penicillamine on pulmonary findings in systemic sclerosis.
    Steen VD; Owens GR; Redmond C; Rodnan GP; Medsger TA
    Arthritis Rheum; 1985 Aug; 28(8):882-8. PubMed ID: 4026885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.